Role of the Specialized Proresolving Mediator Resolvin D1 in Systemic Lupus Erythematosus: Preliminary Results

Figure 3

(a) Levels of resolvin D1 (RvD1) in plasma from SLE patients with low C4 levels (<0.1 g/l) () and SLE patients with normal C4 levels (>0.1 g/l) (). (b) Levels of resolvin D1 (RvD1) in plasma from SLE patients with low C3 levels (<0.9 g/l) () and SLE patients with normal C4 levels (>0.9 g/l) (). (c) Levels of resolvin D1 (RvD1) in plasma from anti-dsDNA antibody-positive SLE patients () and anti-dsDNA antibody-negative SLE patients (). (d) Levels of resolvin D1 (RvD1) in plasma from SLE patients with SELENA-SLEDAI ≤ 3 () and SLE patients with SELENA-SLEDAI > 3 (). (e) Levels of resolvin D1 (RvD1) in plasma from SLE patients with SDI = 0 () and SLE patients with SDI ≥ 1 (). (f) Levels of resolvin D1 (RvD1) in plasma from SLE patients without antiphospholipid syndrome (APS) () and SLE patients with APS (). Data are expressed as pg/ml, median (horizontal bar) with 25th and 75th percentile (boxes), and minimum and maximum (bars) ().

(a)

(b)

(c)

(d)

(e)

(f)